Visual Outcome at 4 Years Following Plaque Radiotherapy and Prophylactic Intravitreal Bevacizumab (Every 4 Months for 2 Years) for Uveal Melanoma
JAMA Ophthalmology | December 12, 2019 | Volume: 138 | Issue: 2 | Pages: 136
10.1001/jamaophthalmol.2019.5132
| PMID 31830238